Education
About Us
Working with TipRanks
Follow Us
Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
RESEARCH TOOLSreports
Comparison Results
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$29.80
HK$46.13B
―
152.54%
1 Buy
1 Hold
0 Sell
Moderate Buy
RemeGen Co. Ltd. Class H
HK$88.00
HK$51.64B
―
617.78%
0 Buy
2 Hold
1 Sell
Moderate Sell
Shanghai Henlius Biotech, Inc. Class H
HK$79.15
HK$45.60B
48.33
221.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascentage Pharma Group International
HK$80.80
HK$30.80B
―
149.00%
1 Buy
1 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
29.80
18.26
158.23%
DE:1ZLB
Zai Lab Ltd
2.76
1.15
71.43%
HK:9966
Alphamab Oncology
9.14
6.59
258.43%
HK:9995
RemeGen Co. Ltd. Class H
88.00
75.74
617.78%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
74.00
51.00
221.74%
HK:6855
Ascentage Pharma Group International
80.80
46.90
138.35%